Our results show that TRE did not improve peripheral and hepatic insulin sensitivity, skeletal muscle mitochondrial function, energy metabolism or hepatic lipid content, all of which are known to be affected in type 2 diabetes mellitus [25–29]. The gene discussed is INS; the disease is type 2 diabetes mellitus.